Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 264 of the 264 references it cites were found in a registry or an index.

Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease

Open access
Rani, Shital, Dhar, Sudhrita Basu, Khajuria, Akhil, Gupta, Dikshi, Jaiswal, Pradeep Kumar, Singla, Neha, Kaur, Mandeep, Singh, Gurpal, Barnwal, Ravi Pratap · 2023 · Cellular and Molecular Neurobiology

Abstract

The development of early non-invasive diagnosis methods and identification of novel biomarkers are necessary for managing Alzheimer's disease (AD) and facilitating effective prognosis and treatment. AD has multi-factorial nature and involves complex molecular mechanism, which causes neuronal degeneration. The primary challenges in early AD detection include patient heterogeneity and lack of precise diagnosis at the preclinical stage. Several cerebrospinal fluid (CSF) and blood biomarkers have been proposed to show excellent diagnosis ability by identifying tau pathology and cerebral amyloid beta (Aβ) for AD. Intense research endeavors are being made to develop ultrasensitive detection techniques and find potent biomarkers for early AD diagnosis. To mitigate AD worldwide, understanding various CSF biomarkers, blood biomarkers, and techniques that can be used for early diagnosis is imperative. This review attempts to provide information regarding AD pathophysiology, genetic and non-genetic factors associated with AD, several potential blood and CSF biomarkers, like neurofilament light, neurogranin, Aβ, and tau, along with biomarkers under development for AD detection. Besides, numerous techniques, such as neuroimaging, spectroscopic techniques, biosensors, and neuroproteomics, which are being explored to aid early AD detection, have been discussed. The insights thus gained would help in finding potential biomarkers and suitable techniques for the accurate diagnosis of early AD…

Overview

Integrity signals

Registry

Crossref · 10.1007/s10571-023-01330-y

Cites

264 of 264 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 263 references

Research works printed but not linked: 5

  1. Crist AM, Hinkle KM, Wang X et al (2020) A novel tau binding partner SERPINA5 Results Bulk transcriptional profiling of hippocampal vulnerability in AD. Springer, New York
  2. Hampel H, Lista S, Vanmechelen E et al (2020) β -Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification. Alzheimer’s Dis 3:1–14
  3. Kepp KP (2012) Bioinorganic chemistry of Alzheimer ’ s disease. Bioorg Chem 112:5193
  4. Lambert JC, Ibrahim-Verbaas CA, Harold D et al (2013b) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45:1452–1458. https://doi.org/10.1038/ng.2802 · DOI · Paper page
  5. Wilson MS, Metink-Kane MM (2012) 基因的改变NIH Public Access. Bone 23:1–7. https://doi.org/10.1146/annurev-statistics-022513-115611.Brain · doi:10.1146/annurev-statistics-022513-115611.brain

Cited by

See all 48

Metadata

Authors
Rani, S., Dhar, S. B., Khajuria, A., Gupta, D., Jaiswal, P. K., Singla, N., Kaur, M., Singh, G., & Barnwal, R. P.
Affiliations
  • Panjab University (IN)
  • Texas A&M University (US)
Corresponding author
  • Rani, Shital
  • Dhar, Sudhrita Basu
  • Khajuria, Akhil
  • Gupta, Dikshi
  • Jaiswal, Pradeep Kumar
  • Singla, Neha
  • Kaur, Mandeep
  • Singh, Gurpal
  • Barnwal, Ravi Pratap
Venue
Cellular and Molecular Neurobiology
Published
2023-02-27
Volume
43
Issue
6
Pages
2491-2523
ISSN
  • 0272-4340 (ISSN-L)
  • 1573-6830
OpenAlex
W4322495020
Cited by
48
References
263
Citations by year
2026: 16 · 2025: 13 · 2024: 13 · 2023: 6
FWCI
2.19
Type
journal article
Language
en
Open access
Licence
Locations
  • Cellular and Molecular Neurobiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Indian Council of Medical Research
  • Science and Engineering Research Board
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, early diagnosis, biomarkers, cerebrospinal fluid biomarkers, blood biomarkers, tau pathology, amyloid-beta, neurofilament light chain, neurogranin, neuroimaging, spectroscopic methods, biosensors, neuroproteomics, preclinical Alzheimer's disease, genetic risk factors, non-genetic risk factors
MeSH terms
Alzheimer Disease, Humans, Biomarkers, Amyloid beta-Peptides, tau Proteins, Early Diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease. https://app.cochat.ai/papers/10.1007/s10571-023-01330-y
The paper
Rani, S., Dhar, S. B., Khajuria, A., Gupta, D., Jaiswal, P. K., Singla, N., Kaur, M., Singh, G., & Barnwal, R. P. (2023). Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-023-01330-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.